Public Health Relevance

/Relevance The goal of this project is to develop a 3D vascular tissue model to investigate the early cellular mechanisms associated with atherosclerosis, as an improvement over the existing 2D models. Such a model will make it possible to study solute concentration gradients and their effect on the cells within the model. Successful completion of this project will result in a 3D vascular tissue model that can be used to both develop and test therapeutics for atherosclerosis and to prevent further complications like heart disease (the leading cause of death in the U.S.).

Agency
National Institute of Health (NIH)
Institute
National Institute of Biomedical Imaging and Bioengineering (NIBIB)
Type
Academic Research Enhancement Awards (AREA) (R15)
Project #
1R15EB009527-01
Application #
7646972
Study Section
Bioengineering, Technology and Surgical Sciences Study Section (BTSS)
Program Officer
Erim, Zeynep
Project Start
2009-05-01
Project End
2012-04-30
Budget Start
2009-05-01
Budget End
2012-04-30
Support Year
1
Fiscal Year
2009
Total Cost
$221,550
Indirect Cost
Name
Oklahoma State University Stillwater
Department
Engineering (All Types)
Type
Schools of Engineering
DUNS #
049987720
City
Stillwater
State
OK
Country
United States
Zip Code
74078
Fennell, Christopher J; Ghousifam, Neda; Haseleu, Jennifer M et al. (2018) Computational Signaling Protein Dynamics and Geometric Mass Relations in Biomolecular Diffusion. J Phys Chem B 122:5599-5609
Ghousifam, Neda; Mortazavian, Hamid; Bhowmick, Rudra et al. (2017) A three-dimensional in vitro model to demonstrate the haptotactic effect of monocyte chemoattractant protein-1 on atherosclerosis-associated monocyte migration. Int J Biol Macromol 97:141-147
Leemasawatdigul, Krisada; Gappa-Fahlenkamp, Heather (2012) Development of a mathematical model to describe the transport of monocyte chemoattractant protein-1 through a three-dimensional collagen matrix. Cardiovasc Pathol 21:219-28
Leemasawatdigul, Krisada; Gappa-Fahlenkamp, Heather (2011) Effect of storage conditions on the stability of recombinant human MCP-1/CCL2. Biologicals 39:29-32